Enablex and Tamsulosin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enablex (darifenacin hydrobromide) and Tamsulosin (tamsulosin). Common drug interactions include chronic kidney disease among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Enablex and Tamsulosin. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Enablex?

Enablex has active ingredients of darifenacin hydrobromide. It is often used in urge incontinence. eHealthMe is studying from 4,934 Enablex users. Check the latest studies of Enablex.

What is Tamsulosin?

Tamsulosin has active ingredients of tamsulosin. It is often used in prostate examination abnormal. eHealthMe is studying from 72,635 Tamsulosin users. Check the latest studies of Tamsulosin.



On Jul, 11, 2026

30 people who take Enablex and Tamsulosin together, and have interactions are studied.

Enablex and Tamsulosin drug interactions.

What are the common drug interactions of Enablex and Tamsulosin, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Abdominal pain upper
  4. Adhesion
  5. Arthralgia (joint pain)
  6. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  7. Bladder disorder
  8. Breast mass
  9. Burning sensation
  10. Cataract (clouding of the lens inside the eye)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fall
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Urinary retention (the inability to completely or partially empty the bladder)
  5. Urinary tract infection
  6. Death
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Drug level increased
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

What are the common drug interactions of Enablex and Tamsulosin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain upper
  2. Adhesion
  3. Arthralgia (joint pain)
  4. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  5. Bladder disorder
  6. Breast mass
  7. Burning sensation
  8. Cataract (clouding of the lens inside the eye)
  9. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
  10. Contusion (a type of hematoma of tissue in which capillaries)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

60+:

  1. Cardiac failure congestive
  2. Dyspnoea (difficult or laboured respiration)
  3. Urinary retention (the inability to completely or partially empty the bladder)
  4. Urinary tract infection
  5. Death
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Adenocarcinoma pancreas (cancer of pancreas)
  9. Cardioversion
  10. Cerebellar haematoma (blood collection in cerebeller)

What are the existing conditions these people have? *

  1. Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 6 people, 20.00%
  2. Allergic Rhinitis: 5 people, 16.67%
  3. Asthma: 5 people, 16.67%
  4. Infection: 4 people, 13.33%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.33%
  6. High Blood Pressure: 4 people, 13.33%
  7. Anaemia (lack of blood): 3 people, 10.00%
  8. Depression: 3 people, 10.00%
  9. Diarrhea: 3 people, 10.00%
  10. Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Enablex and Tamsulosin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Enablex and Tamsulosin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enablex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tamsulosin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enablex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tamsulosin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on darifenacin hydrobromide and tamsulosin (the active ingredients of Enablex and Tamsulosin, respectively), and Enablex and Tamsulosin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: